Page 78 - AN-2-2
P. 78
Advanced Neurology Role of immunosuppressants in autism
neurodevelopmental pathways in autism spectrum disorder: https://doi.org/10.1002/cti2.1211
A review of signaling mechanisms and crosstalk. J Neurodev 19. Malek M, Ashraf-Ganjouei A, Moradi K, et al., 2020,
Disord, 11: 10.
Prednisolone as adjunctive treatment to risperidone in children
https://doi.org/10.1186/s11689-019-9268-y with regressive type of autism spectrum disorder: A randomized,
placebo-controlled trial. Clin Neuropharmacol, 43: 39–45.
8. Cezar LC, Kirsten TB, da Fonseca CC, et al., 2018, Zinc as a
therapy in a rat model of autism prenatally induced by valproic https://doi.org/10.1097/wnf.0000000000000382
acid. Prog Neuropsychopharmacol Biol Psychiatry 84: 173–180.
20. Hollville E, Deshmukh M, 2018, Physiological functions of
https://doi.org/10.1016/j.pnpbp.2018.02.008 non-apoptotic caspase activity in the nervous system. Semin
Cell Dev Biol, 82: 127–136.
9. Lacivita E, Perrone R, Margari L, et al., 2017, Targets for
drug therapy for autism spectrum disorder: Challenges and https://doi.org/10.1016/j.semcdb.2017.11.037
future directions. J Med Chem, 60: 9114–9141. 21. Lawrie SM, Buechel C, Whalley HC, et al., 2022, Reduced
https://doi.org/10.1021/acs.jmedchem.7b00965 frontotemporal functional connectivity in schizophrenia associated
with auditory hallucinations. Biol Psychiatry, 51: 1008–1011.
10. He JL, Oeltzschner G, Mikkelsen M, et al., 2021, Region-
specific elevations of glutamate + glutamine correlate with https://doi.org/10.1016/s0006-3223(02)01316-1
the sensory symptoms of autism spectrum disorders. Transl 22. Thomas MS, Davis R, Karmiloff-Smith A, et al., 2015, The
Psychiatry, 11: 411.
over-pruning hypothesis of autism. Dev Sci, 19: 1–22.
https://doi.org/10.31234/osf.io/n4ujh
23. Morales-Torres S, 2022, Study on Sub-lethal Executioner
11. Sharma A, Mehan S, 2021, Targeting PI3K-AKT/mTOR signaling Caspase Activation in the Mammalian Nervous System.
in the prevention of autism. Neurochem Int, 147: 105067. Oakland: University of California.
https://doi.org/10.1016/j.neuint.2021.105067 24. Goto M, Tanimoto K, Horiuchi Y, 1980, Natural cell
mediated cytotoxicity in systemic lupus erythematosus.
12. Van Gent T, Heijnen CJ, Treffers PD, 1997, Autism and the
immune system. J Child Psychol Psychiatry, 38: 337–349. Arthritis Rheum, 23: 1274–1281.
https://doi.org/10.1002/art.1780231108
https://doi.org/10.1111/j.1469-7610.1997.tb01518.x
25. Waksman BH, 1981, Current trends in multiple sclerosis
13. Atladóttir HO, Pedersen MG, Thorsen P, et al., 2009,
Association of family history of autoimmune diseases and research. Immunol Today, 2: 87–93.
autism spectrum disorders. Pediatrics, 124: 687–694. https://doi.org/10.1016/0167-5699(81)90038-4
https://doi.org/10.1542/peds.2008-2445 26. Goto M, Tanimoto K, Chihara T, et al., 1981, Natural cell-
mediated cytotoxicity in Sjögren’s syndrome and rheumatoid
14. Croen LA, Grether JK, Yoshida CK, et al., 2005, Maternal
autoimmune diseases, asthma and allergies, and childhood arthritis. Arthritis Rheum, 24: 1377–1382.
autism spectrum disorders: A case-control study. Arch https://doi.org/10.1002/art.1780241107
Pediatr Adolesc Med, 159: 151–157.
27. García-Domínguez I, Suárez-Pereira I, Santiago M,
https://doi.org/10.1001/archpedi.159.2.151 et al., 2021, Selective deletion of Caspase-3 gene in the
dopaminergic system exhibits autistic-like behaviour. Prog
15. Careaga M, Van de Water J, Ashwood P, 2010, Immune
dysfunction in autism: A pathway to treatment. Neuropsychopharmacol Biol Psychiatry, 104: 110030.
Neurotherapeutics, 7: 283–292. https://doi.org/10.1016/j.pnpbp.2020.110030
https://doi.org/10.1016/j.nurt.2010.05.003 28. Warren RP, Foster A, Margaretten NC, 1987, Reduced
natural killer cell activity in autism. J Am Acad Child Adolesc
16. Massrali A, Adhya D, Srivastava DP, et al., 2022, Virus- Psychiatry, 26: 333–335.
induced maternal immune activation as an environmental
factor in the etiology of autism and schizophrenia. Front https://doi.org/10.1097/00004583-198705000-00008
Neurosci, 16: 834058.
29. Meimand SE, Rostam-Abadi Y, Rezaei N, 2021, Autism spectrum
https://doi.org/10.3389/fnins.2022.834058 disorders and natural killer cells: A review on pathogenesis and
treatment. Expert Rev Clin Immunol, 17: 27–35.
17. Caron A, Richard D, Laplante M, 2015, The roles of mTOR
complexes in lipid metabolism. Annu Rev Nutr, 35: 321–348. https://doi.org/10.1080/1744666x.2020.1850273
https://doi.org/10.1146/annurev-nutr-071714-034355 30. Ganesan H, Balasubramanian V, Iyer M, et al., 2019, mTOR
signalling pathway-A root cause for idiopathic autism? BMB
18. Sotgiu S, Manca S, Gagliano A, et al., 2020, Immune
regulation of neurodevelopment at the mother-foetus Rep, 52: 424–433.
interface: The case of autism. Clin Transl Immunol, 9: e1211. https://doi.org/10.5483/bmbrep.2019.52.7.137
Volume 2 Issue 2 (2023) 18 https://doi.org/10.36922/an.391

